help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2017
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clayton, P. E.
Right arrow Articles by Rogol, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clayton, P. E.
Right arrow Articles by Rogol, A.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 3 804-810
Copyright © 2007 by The Endocrine Society


CONSENSUS STATEMENT

Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society

P. E. Clayton, S. Cianfarani, P. Czernichow, G. Johannsson, R. Rapaport and A. Rogol

University of Manchester (P.E.C.), Manchester M13 9PL, United Kingdom; "Tor Vergata" University (S.C.), 00133 Rome, Italy; Robert Debre Hospital (P.C.), 75019 Paris, France; Sahlgrenska University Hospital (G.J.), SE-41345 Gothenburg, Sweden; Mount Sinai School of Medicine (R.R.), New York, New York 10029; and University of Virginia (A.R.), Charlottesville, Virginia 22911

Address all correspondence and requests for reprints to: Alan D. Rogol, ODR Consulting and University of Virginia, 685 Explorers Road, Charlottesville, Virginia 22911-8441. E-mail: arogol{at}cstone.net.

Objective: Low birth weight remains a major cause of morbidity and mortality in early infancy and childhood. It is associated with an increased risk of health problems later in life, particularly coronary heart disease and stroke. A meeting was convened to identify the key health issues facing a child born small for gestational age (SGA) and to propose management strategies.

Participants: There were 42 participants chosen for their expertise in obstetrics, peri- and neonatal medicine, pediatrics, pediatric and adult endocrinology, epidemiology, and pharmacology.

Evidence: Written materials were exchanged, reviewed, revised, and then made available to all. This formed the basis for discussions at the meeting. Where published data were not available or adequate, discussion was based on expert clinical opinions.

Consensus Process: Each set of questions was considered by all and then discussed in plenary sessions with consensus and unresolved issues identified. The consensus statement was prepared in plenary sessions and then edited by the group chairs and shared with all participants.

Conclusions: The diagnosis of SGA should be based on accurate anthropometry at birth including weight, length, and head circumference. We recommend early surveillance in a growth clinic for those without catch-up. Early neurodevelopment evaluation and interventions are warranted in at-risk children. Endocrine and metabolic disturbances in the SGA child are recognized but infrequent. For the 10% who lack catch-up, GH treatment can increase linear growth. Early intervention with GH for those with severe growth retardation (height SD score, <–2.5; age, 2–4 yr) should be considered at a dose of 35–70 µg/kg·d. Long-term surveillance of treated patients is essential. The associations at a population level between low birth weight, including SGA, and coronary heart disease and stroke in later life are recognized, but there is inadequate evidence to recommend routine health surveillance of all adults born SGA outside of normal clinical practice.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Cohen, A. D. Rogol, C. L. Deal, P. Saenger, E. O. Reiter, J. L. Ross, S. D. Chernausek, M. O. Savage, J. M. Wit, and on behalf of the 2007 ISS Consensus Workshop parti
Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4210 - 4217.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Meas, S. Deghmoun, P. Armoogum, C. Alberti, and C. Levy-Marchal
Consequences of Being Born Small for Gestational Age on Body Composition: An 8-Year Follow-Up Study
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3804 - 3809.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. H. Willemsen, S. P. Willemsen, and A. C. S. Hokken-Koelega
Longitudinal Changes in Insulin Sensitivity and Body Composition of Small-For-Gestational-Age Adolescents after Cessation of Growth Hormone Treatment
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3449 - 3454.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, A.-K. Seidel, D. D. Martin, R. Schweizer, C. P. Schwarze, H. A. Wollmann, T. Eggermann, and M. B. Ranke
The Endocrine Phenotype in Silver-Russell Syndrome Is Defined by the Underlying Epigenetic Alteration
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1402 - 1407.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. J. de Ridder, T. Stijnen, and A. C. S. Hokken-Koelega
Prediction Model for Adult Height of Small for Gestational Age Children at the Start of Growth Hormone Treatment
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Argente, R. Gracia, L. Ibanez, A. Oliver, E. Borrajo, A. Vela, J. P. Lopez-Siguero, M. L. Moreno, F. Rodriguez-Hierro, and on behalf of the Spanish SGA Working Group
Improvement in Growth after Two Years of Growth Hormone Therapy in Very Young Children Born Small for Gestational Age and without Spontaneous Catch-Up Growth: Results of a Multicenter, Controlled, Randomized, Open Clinical Trial
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3095 - 3101.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E M Delemarre, J Rotteveel, and H A D.-v. de Waal
Metabolic implications of GH treatment in small for gestational age
Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S47 - S50.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter
Small for Gestational Age: Short Stature and Beyond
Endocr. Rev., April 1, 2007; 28(2): 219 - 251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society